Overview

Use of Levemir® Improves Metabolic and Clinical Status in Cystic Fibrosis-related Diabetes (CFRD)

Status:
Terminated
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
This is a study to find out if Levemir® (a long acting or basal insulin) is safe and effective in treating cystic fibrosis related diabetes (CFRD).
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Nationwide Children's Hospital
Collaborator:
Novo Nordisk A/S
Treatments:
Insulin Detemir